Demaria, Sandra

Publications

Sort by

Co-Author Network

selected publications

The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Science immunology. 2023 Review GET IT
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6^th annual ImmunoRad conference. Oncoimmunology. 2023 Review GET IT
Times cited: 511
Immunologically relevant effects of radiation therapy on the tumor microenvironment. Essays in biochemistry. 2023 Academic Article GET IT
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer. Frontiers in oncology. 2023 Review GET IT
Times cited: 12
Quantitative assessment of mitophagy in irradiated cancer cells. Methods in cell biology. 2022 Academic Article GET IT
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021. Journal of translational medicine. 2022 Academic Article GET IT
Times cited: 2
ATM Modulates Nuclear Mechanics by Regulating Lamin A Levels. Frontiers in cell and developmental biology. 2022 Academic Article GET IT
Times cited: 73
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021. Journal of translational medicine. 2022 Academic Article GET IT
Radiation therapy-induced remodeling of the tumor immune microenvironment. Seminars in cancer biology. 2022 Review GET IT
Times cited: 10
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Science translational medicine. 2022 Academic Article GET IT
Times cited: 7
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer. NPJ breast cancer. 2022 Academic Article GET IT
Times cited: 99
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ breast cancer. 2021 Review GET IT
Times cited: 467
Something Old and Something New to Unleash the Power of Natural Killer Cells against Metastases. Cancer immunology research. 2021 Comment GET IT
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology. 2021 Academic Article GET IT
Times cited: 25
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. Nature communications. 2021 Academic Article GET IT
Times cited: 17
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy). Journal of translational medicine. 2021 Academic Article GET IT
Times cited: 1
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?. Journal for immunotherapy of cancer. 2021 Review GET IT
Times cited: 85
The role of radiotherapy in the age of immunotherapy. Japanese journal of clinical oncology. 2021 Review GET IT
Times cited: 15
Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
Times cited: 9
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control. The Journal of clinical investigation. 2021 Academic Article GET IT
Times cited: 75
Liver Metastasis Irradiation Can Restore Immunotherapeutic Responsiveness. Trends in immunology. 2021 Comment GET IT
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides. Trends in cancer. 2021 Review GET IT
Times cited: 20
Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates. Advanced therapeutics. 2020 Academic Article GET IT
Times cited: 20
Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer. Cancer immunology research. 2020 Academic Article GET IT
Times cited: 28
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade. Oncoimmunology. 2020 Academic Article GET IT
Times cited: 24
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant. Pharmaceutics. 2020 Academic Article GET IT
Times cited: 14
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy). Journal of translational medicine. 2020 Academic Article GET IT
Times cited: 3
Future of Radiation and Immunotherapy. International journal of radiation oncology, biology, physics. 2020 Editorial Article GET IT
Times cited: 13
Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1. International journal of radiation oncology, biology, physics. 2020 Academic Article GET IT
Times cited: 25
IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection. Oncoimmunology. 2020 Review GET IT
Times cited: 3
Radiation-induced Adaptive Response: New Potential for Cancer Treatment. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Review GET IT
Times cited: 22
Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses. Cancer immunology research. 2020 Academic Article GET IT
Times cited: 22
Emerging technologies for local cancer treatment. Advanced therapeutics. 2020 Academic Article GET IT
Times cited: 22
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials. NPJ breast cancer. 2020 Review GET IT
Times cited: 8
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. NPJ breast cancer. 2020 Academic Article GET IT
Times cited: 131
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group. NPJ breast cancer. 2020 Review GET IT
Times cited: 718
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. The Journal of pathology. 2020 Review GET IT
Times cited: 106
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal for immunotherapy of cancer. 2020 Review GET IT
Times cited: 459
The abscopal effect 67 years later: from a side story to center stage. The British journal of radiology. 2020 Review GET IT
Times cited: 53
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. Cancer immunology research. 2020 Academic Article GET IT
Times cited: 69
Exercise reduces immune suppression and breast cancer progression in a preclinical model. Oncotarget. 2020 Academic Article GET IT
Times cited: 52
Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment. Cancer treatment and research. 2020 Academic Article GET IT
Times cited: 8
Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary Intervention. Cancer immunology research. 2019 Academic Article GET IT
Times cited: 8
Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial. Journal for immunotherapy of cancer. 2019 Comment GET IT
Times cited: 10
The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018. Journal for immunotherapy of cancer. 2019 Conference Paper GET IT
Times cited: 4
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer. Journal of the National Cancer Institute. 2019 Academic Article GET IT
Times cited: 30
Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients. Journal for immunotherapy of cancer. 2019 Academic Article GET IT
Times cited: 27
Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system. Genome medicine. 2019 Review GET IT
Times cited: 131
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod. Scientific reports. 2019 Academic Article GET IT
Times cited: 20
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Academic Article GET IT
Times cited: 96
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 393
Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nature medicine. 2018 Academic Article GET IT
Times cited: 508
Pegylated Bovine Carboxyhemoglobin (SANGUINATE) in a Jehovah's Witness Undergoing Liver Transplant: A Case Report. 2018 GET IT
Times cited: 8
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer. Oncoimmunology. 2018 Academic Article GET IT
Times cited: 135
Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect. Trends in immunology. 2018 Review GET IT
Times cited: 249
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning. Seminars in cancer biology. 2018 Review GET IT
Times cited: 92
Cytosolic DNA Sensing in Organismal Tumor Control. Cancer cell. 2018 Review GET IT
Times cited: 149
Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2018 Academic Article GET IT
Times cited: 24
Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs. Cancer immunology research. 2018 Academic Article GET IT
Times cited: 208
Understanding Responses to Stereotactic Body Radiotherapy and Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Letter GET IT
Times cited: 8
The Future of Radiobiology. Journal of the National Cancer Institute. 2018 Academic Article GET IT
Times cited: 57
SnapShot: CGAS-STING Signaling. Cell. 2018 Review GET IT
Times cited: 97
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 164
Using immunotherapy to boost the abscopal effect. Nature reviews. Cancer. 2018 Review GET IT
Times cited: 658
Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation. Radiation research. 2018 Academic Article GET IT
Times cited: 40
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers. Seminars in cancer biology. 2017 Review GET IT
Times cited: 44
TREX1 is a checkpoint for innate immune sensing of DNA damage that fosters cancer immune resistance. Emerging topics in life sciences. 2017 Academic Article GET IT
Times cited: 7
Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells. Cancer immunology research. 2017 Academic Article GET IT
Times cited: 137
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016. Journal of translational medicine. 2017 Conference Paper GET IT
Times cited: 15
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy. Journal of translational medicine. 2017 Editorial Article GET IT
Times cited: 21
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. Advances in anatomic pathology. 2017 Review GET IT
Times cited: 417
Immune recognition of irradiated cancer cells. Immunological reviews. 2017 Review GET IT
Times cited: 61
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. Seminars in cancer biology. 2017 Review GET IT
Times cited: 257
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research. Advances in anatomic pathology. 2017 Review GET IT
Times cited: 391
Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 2017 Review GET IT
Times cited: 56
Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Review GET IT
Times cited: 125
TREX1 dictates the immune fate of irradiated cancer cells. Oncoimmunology. 2017 Academic Article GET IT
Times cited: 72
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape. European journal of cancer (Oxford, England : 1990). 2017 Review GET IT
Times cited: 367
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nature communications. 2017 Academic Article GET IT
Times cited: 992
Heavy Metal to Rock the Immune Infiltrate. Trends in immunology. 2017 Comment GET IT
Times cited: 7
Barriers to Radiation-Induced In Situ Tumor Vaccination. Frontiers in immunology. 2017 Review GET IT
Times cited: 30
PTEN at the interface of immune tolerance and tumor suppression. Frontiers in biology. 2017 Academic Article GET IT
Times cited: 17
Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer. Oncoimmunology. 2016 Academic Article GET IT
Times cited: 9
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nature reviews. Clinical oncology. 2016 Review GET IT
Times cited: 229
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. Journal of translational medicine. 2016 Conference Paper GET IT
Times cited: 16
Current clinical trials testing the combination of immunotherapy with radiotherapy. Journal for immunotherapy of cancer. 2016 Academic Article GET IT
Times cited: 464
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015. Journal of translational medicine. 2016 Academic Article GET IT
Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 2016 Review GET IT
Times cited: 653
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Academic Article GET IT
Times cited: 183
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule. Journal for immunotherapy of cancer. 2016 Academic Article GET IT
Times cited: 4452
Radiotherapy: Changing the Game in Immunotherapy. Trends in cancer. 2016 Review GET IT
Times cited: 231
Can abscopal effects of local radiotherapy be predicted by modeling T cell trafficking?. Journal for immunotherapy of cancer. 2016 Academic Article GET IT
Times cited: 257
Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness. Cancer immunology research. 2016 Academic Article GET IT
Times cited: 73
Emerging Opportunities and Challenges in Cancer Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Review GET IT
Times cited: 210
Subverting misconceptions about radiation therapy. Nature immunology. 2016 Letter GET IT
Times cited: 1
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy. EBioMedicine. 2016 Academic Article GET IT
Times cited: 22
Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression. Oncology (Williston Park, N.Y.). 2015 Review GET IT
Times cited: 84
Role of Local Radiation Therapy in Cancer Immunotherapy. JAMA oncology. 2015 Review GET IT
Times cited: 467
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014. Journal of translational medicine. 2015 Conference Paper GET IT
Times cited: 11
Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC). Oncoimmunology. 2015 Academic Article GET IT
Times cited: 317
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine. 2015 Review GET IT
Times cited: 127
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. The Lancet. Oncology. 2015 Academic Article GET IT
Times cited: 475
TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity. Cancer research. 2015 Academic Article GET IT
Times cited: 381
Combination of radiotherapy and immune checkpoint inhibitors. Seminars in radiation oncology. 2015 Review GET IT
Times cited: 114
Current clinical trials testing combinations of immunotherapy and radiation. Seminars in radiation oncology. 2015 Review GET IT
Times cited: 113
Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014 Review GET IT
Times cited: 264
Combinations of immunotherapy and radiation in cancer therapy. Frontiers in oncology. 2014 Review GET IT
Times cited: 3850
Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes. Journal for immunotherapy of cancer. 2014 Academic Article GET IT
Times cited: 263
Densely ionizing radiation acts via the microenvironment to promote aggressive Trp53-null mammary carcinomas. Cancer research. 2014 Academic Article GET IT
Times cited: 22
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 930
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. 2014 GET IT
Times cited: 1741
Clinical trial evidence of the antitumor activity of topical imiquimod for breast cancer skin metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Letter GET IT
Times cited: 8
The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation. Radiation research. 2014 Review GET IT
Times cited: 68
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology. 2014 Academic Article GET IT
Times cited: 106
An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. 2013 GET IT
Times cited: 541
The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 66
Radiotherapy effects on anti-tumor immunity: implications for cancer treatment. Frontiers in oncology. 2013 Academic Article GET IT
Times cited: 44
Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 186
Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies. Immunotherapy. 2013 Editorial Article GET IT
Times cited: 3
Combining radiotherapy and cancer immunotherapy: a paradigm shift. Journal of the National Cancer Institute. 2013 Review GET IT
Times cited: 764
Radiation therapy to convert the tumor into an in situ vaccine. International journal of radiation oncology, biology, physics. 2012 Editorial Article GET IT
Times cited: 211
Radiation as an immunological adjuvant: current evidence on dose and fractionation. Frontiers in oncology. 2012 Academic Article GET IT
Times cited: 28
Invariant NKT cells as novel targets for immunotherapy in solid tumors. Clinical & developmental immunology. 2012 Review GET IT
Times cited: 29
Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 123
Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects. The Journal of clinical investigation. 2012 Academic Article GET IT
Times cited: 157
Role of T lymphocytes in tumor response to radiotherapy. Frontiers in oncology. 2012 Academic Article GET IT
Times cited: 547
The convergence of radiation and immunogenic cell death signaling pathways. Frontiers in oncology. 2012 Academic Article GET IT
Times cited: 286
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 163
TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 191
The numbers of FoxP3+ lymphocytes in sentinel lymph nodes of breast cancer patients correlate with primary tumor size but not nodal status. Cancer investigation. 2011 Academic Article GET IT
Times cited: 16
Defining the role of the immune system in cancer treatment: highlights from the Immunochemotherapy Conference. Expert review of anticancer therapy. 2011 Conference Paper GET IT
Times cited: 2
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?. Cancer immunology, immunotherapy : CII. 2011 Academic Article GET IT
Times cited: 26
Cancer and inflammation: promise for biologic therapy. Journal of immunotherapy (Hagerstown, Md. : 1997). 2010 Review GET IT
Times cited: 263
Introduction to the special BR-RIDGE issue. Radiation research. 2010 Article GET IT
Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model. Radiation research. 2010 Academic Article GET IT
Times cited: 53
Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation. Radiation research. 2010 Academic Article GET IT
Times cited: 126
Research highlights: Immunotherapy. Immunotherapy. 2009 Comment GET IT
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 1180
Systemic effects of local radiotherapy. The Lancet. Oncology. 2009 Review GET IT
Times cited: 716
Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 79
Local control by radiotherapy: is that all there is?. Breast cancer research : BCR. 2008 Review GET IT
Times cited: 53
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. Journal of immunology (Baltimore, Md. : 1950). 2008 Academic Article GET IT
Times cited: 520
Effects of chemoradiation on tumor-host interactions: the immunologic side. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Letter GET IT
Times cited: 34
Sensors of ionizing radiation effects on the immunological microenvironment of cancer. International journal of radiation biology. 2007 Review GET IT
Times cited: 101
The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 125
Combining radiotherapy and immunotherapy: a revived partnership. International journal of radiation oncology, biology, physics. 2005 Review GET IT
Times cited: 287
Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain. Laboratory investigation; a journal of technical methods and pathology. 2005 Academic Article GET IT
Times cited: 129
Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 785
Select forms of tumor cell apoptosis induce dendritic cell maturation. Journal of leukocyte biology. 2004 Academic Article GET IT
Times cited: 57
HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase. Infection and immunity. 2004 Academic Article GET IT
Times cited: 42
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. International journal of radiation oncology, biology, physics. 2004 Academic Article GET IT
Times cited: 1002
Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 266
Peptide loading of nascent MHC class I molecules. Archivum immunologiae et therapiae experimentalis. 2001 Review GET IT
Times cited: 4
Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment. Clinical cancer research : an official journal of the American Association for Cancer Research. 2000 Academic Article GET IT
Times cited: 124
Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase. Human immunology. 2000 Academic Article GET IT
Times cited: 26
Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase. Human immunology. 1999 Academic Article GET IT
Times cited: 15
Fine needle aspiration of primary pleomorphic liposarcoma of the breast. A case report. 1999 GET IT
Times cited: 13
Multilocular thymic cyst with follicular lymphoid hyperplasia in a male infected with HIV. A case report with fine needle aspiration cytology. 1999 GET IT
Times cited: 16
The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: proposed mechanism for soluble HLA release in transplant rejection. Human immunology. 1998 Academic Article GET IT
Times cited: 24
Soluble CD4 induces the binding of human immunodeficiency virus type 1 to cells via the V3 loop of glycoprotein 120 and specific sites in glycoprotein 41. AIDS research and human retroviruses. 1996 Academic Article GET IT
Times cited: 14
Bathophenanthroline disulfonate and soluble CD4 as probes for early events of HIV type 1 entry. AIDS research and human retroviruses. 1995 Academic Article GET IT
Times cited: 5
Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. The Journal of biological chemistry. 1994 Academic Article GET IT
Times cited: 85
CD8 and beta 2-microglobulin-free MHC class I molecules in T cell immunoregulation. International journal of clinical & laboratory research. 1993 Review GET IT
Times cited: 24
The origin and fate of beta 2m-free MHC class I molecules induced on activated T cells. Cellular immunology. 1992 Academic Article GET IT
Times cited: 50
Activation of human CD8-positive T cells via the CD8/HLA class I complex. Cellular immunology. 1990 Academic Article GET IT
Times cited: 5
Increased density of ecto 5' nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Blood. 1989 Academic Article GET IT
Times cited: 18
Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 1988 Academic Article GET IT
Times cited: 56
Definition by CB12 monoclonal antibody of a differentiation marker specific for human monocytes and their bone marrow precursors. Cellular immunology. 1986 Academic Article GET IT
Times cited: 4
Functional and molecular characterization by the CB04 monoclonal antibody of a cell surface structure exerting C3-complement receptor activity. Journal of clinical immunology. 1985 Academic Article GET IT
Times cited: 9
Murine monoclonal antibodies as probes for the phenotypical, functional, and molecular analysis of a discrete peripheral blood lymphocyte population exerting natural killer activity in vitro. Human immunology. 1985 Academic Article GET IT
Times cited: 27

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation awarded by National Cancer Institute Principal Investigator 2022 - 2027
Corroboration the efficacy observed in Project Part 1 and exploration of the mechanisms behind these effects awarded by Boehringer Ingelheim Pharmaceuticals, Inc. (USA) Principal Investigator 2022 - 2023
Hypoxic incubator for physiological cell culture research awarded by National Institutes of Health, Office of the Director Principal Investigator 2022 - 2023
The effects of radiotherapy on the presentation of phosphorylated antigens by cancer cells awarded by Starr Cancer Consortium Principal Investigator 2021 - 2023
Converting HR+ Breast Cancer Into an Individualized Vaccine awarded by United States Department of Defense Principal Investigator 2019 - 2023

Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory awarded by United States Department of Defense Co-Investigator 2021 - 2025
PSMA/MR-guided Stereotactic Body Radiotherapy for High Risk Prostate Cancer awarded by National Cancer Institute Co-Investigator 2020 - 2024
Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancer awarded by Breast Cancer Research Foundation, Inc. Co-Investigator 2022 - 2023
Converting HR+ Breast Cancer Into an Individualized Vaccine awarded by United States Department of Defense Co-Investigator 2019 - 2023
Targeting ART1, a novel immune checkpoint, for the treatment of lung cancer awarded by United States Department of Defense Co-Investigator 2019 - 2023

The impact of hypoxia on radiation induced anti-cancer immunity awarded by American Association for Cancer Research Key Personnel 2021 - 2024

more ...

less ...

Background

education and training

M.D., University of Turin Faculty of Medicine and Surgery (Italy) 1988

Contact

full name

Sandra Demaria

primary email

szd3005@med.cornell.edu

VIVO Weill Cornell Medical College

Sandra Demaria Professor of Radiation Oncology

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email